| Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches MO Idris, AA Yekeen, OS Alakanse, OA Durojaye Journal of Biomolecular Structure and Dynamics 39 (15), 5638-5656, 2021 | 89 | 2021 |
| CHAPERONg: A tool for automated GROMACS-based molecular dynamics simulations and trajectory analyses AA Yekeen, OA Durojaye, MO Idris, HF Muritala, RO Arise Computational and Structural Biotechnology Journal 21, 4849-4858, 2023 | 28 | 2023 |
| Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells S Du, X Song, Y Li, Y Cao, F Chu, OA Durojaye, Z Su, X Shi, J Wang, ... Scientific Reports 10 (1), 11273, 2020 | 22 | 2020 |
| A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans AS Odiba, OA Durojaye, IM Ezeonu, AC Mgbeahuruike, BC Nwanguma Infection and Drug Resistance, 3111-3133, 2022 | 16 | 2022 |
| MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference OA Durojaye, NO Okoro, AS Odiba, BC Nwanguma Scientific Reports 13 (1), 6972, 2023 | 10 | 2023 |
| Identification of a potential mRNA‐based vaccine candidate against the SARS‐CoV‐2 spike glycoprotein: A reverse vaccinology approach OA Durojaye, DM Sedzro, MO Idris, AA Yekeen, AA Fadahunsi, ... ChemistrySelect 7 (7), e202103903, 2022 | 10 | 2022 |
| Evaluation of 6-Gingerol and its modified analogues as therapeutic candidates against Schistosoma mansoni phosphofructokinase OA Durojaye, BC Nwanguma, PE Joshua, JO Ogidigo, S Cosmas, ... VacciMonitor 28 (1), 38-47, 2019 | 10 | 2019 |
| Computer-aided molecular modeling and structural analysis of the human centromere protein–HIKM complex HO Uzoeto, S Cosmas, JN Ajima, AV Arazu, CM Didiugwu, DE Ekpo, ... Beni-Suef University Journal of Basic and Applied Sciences 11 (1), 101, 2022 | 9 | 2022 |
| Mad2 promotes Cyclin B2 recruitment to the kinetochore for guiding accurate mitotic checkpoint S Liu, X Yuan, P Gui, R Liu, O Durojaye, DL Hill, C Fu, X Yao, Z Dou, X Liu EMBO reports 23 (6), e54171, 2022 | 9 | 2022 |
| Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein HO Uzoeto, JN Ajima, AV Arazu, GO Ibiang, S Cosmas, OA Durojaye Journal of Genetic Engineering and Biotechnology 20 (1), 10, 2022 | 9 | 2022 |
| Clinical diagnosis of disease states using enzymes and proteins N Evalde, PO James, O Onuorah, CC Ilo, D Okeowhor, S Cosmas, ... Asian Journal of Biochemistry, Genetics and Molecular Biology 1 (3), 1-6, 2019 | 8 | 2019 |
| Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study OA Durojaye, T Mushiana, HO Uzoeto, S Cosmas, VM Udowo, ... Egyptian Journal of Medical Human Genetics 21, 1-17, 2020 | 7 | 2020 |
| An in-silico pharmacokinetics study on Cis-heptadeca-1, 9-Diene-4, 6-Diyne-3, 8-Diol: A nutraceutical compound with anticancer properties PT Okoli, VC Nzute, OA Durojaye, OH Chielo, QC Ajibo, SI Udo, SM Ezeh Asian Food Science Journal 7, 1-7, 2019 | 7 | 2019 |
| Revolutionizing drug discovery: an AI-powered transformation of molecular docking AA Fadahunsi, HO Uzoeto, NO Okoro, S Cosmas, OA Durojaye, AS Odiba Medicinal Chemistry Research, 1-17, 2024 | 5 | 2024 |
| Csc01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach OA Durojaye, U Ejaz, HO Uzoeto, AA Fadahunsi, AO Opabunmi, DE Ekpo, ... Amino Acids 55 (12), 1745-1764, 2023 | 5 | 2023 |
| Investigation of the MDM2-binding potential of de novo designed peptides using enhanced sampling simulations OA Durojaye, AA Yekeen, MO Idris, NO Okoro, AS Odiba, BC Nwanguma International Journal of Biological Macromolecules 269, 131840, 2024 | 4 | 2024 |
| Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics GO Ibiang, J Malachi, MO Ibiang, DK Chukwudi, OA Durojaye Egyptian Journal of Medical Human Genetics 23, 1-7, 2022 | 4 | 2022 |
| Identifying Potential p53‐MDM2 Interaction Antagonists: An Integrated Approach of Pharmacophore‐Based Virtual Screening, Interaction Fingerprinting, MD Simulation and DFT Studies DM Sedzro, MO Idris, OA Durojaye, AA Yekeen, AA Fadahunsi, ... ChemistrySelect 7 (39), e202202380, 2022 | 4 | 2022 |
| Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders AS Odiba, NO Okoro, OA Durojaye, Y Wu Open Life Sciences 16 (1), 431-441, 2021 | 4 | 2021 |
| Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study JN Nwachukwu, OA Durojaye, UO Njoku, MM Tanze, N Christian, ... African Journal of Biomedical Research 22 (3), 347-352, 2019 | 4 | 2019 |
Idris MukhtarOregon State University, OregonVerified email at mail.ustc.edu.cn